Bioage Labs Is A Clinical Stage Biotechnology Company Based In Richmondcaliforniafounded In 2015The Company Focuses On Developing Therapies That Target The Biological Mechanisms Of Aging To Treat Metabolic And Age Related Diseasesbioage Utilizes A Proprietary Discovery Platform That Integrates Multi Omics Data From Human Cohortsanalyzing Over 65 Million Molecular Measurements To Identify Druggable Targets Linked To Metabolic Dysfunction And Chronic Inflammation The Companyae S Lead Programazelapragis Currently In Phase 2 Trials And Aims To Address Obesity In Older Adultsbioage Is Also Developing Bge 102A Preclinical Candidate Targeting Chronic Inflammation Associated With Appetite Dysregulation And Insulin Resistancetheir Research Is Supported By Prominent Investors And Emphasizes A Data Driven Approach To Extend Healthy Lifespan By Addressing The Root Causes Of Agingco Founded By Ceo Kristen Fortney And Coo Eric Morgenbioage Is Publicly Listed Under The Ticker Bioa
